Acute Respiratory Distress Syndrome News and Research

RSS

Nanoparticle gene delivery system shows promise for treating ARDS

Discovery from the lab of Youyang Zhao, PhD, from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago offers promising treatment approaches for acute respiratory distress syndrome (ARDS) in the elderly that can be caused by severe COVID-19, pneumonia, flu or sepsis. Currently there are no pharmacological or cell-based treatments for ARDS.

19 Sep 2023

Cancer drug could play a role in limiting the damaging effects of lung disease in COVID-19 patients

A cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients, thanks to new research at Hudson Institute of Medical Research.

19 Sep 2023

SARS-CoV-2 infection can exacerbate production of auto-antibodies relating to auto-immune diseases

An article published in NPJ Aging, a Springer Nature journal, reveals that natural production of auto-antibodies increases with age and that infection by SARS-CoV-2 can exacerbate production of auto-antibodies relating to auto-immune diseases, helping to explain why aging increases the chances of developing severe COVID-19.

12 Sep 2023

What factors are associated with readmission in pediatric survivors of acute respiratory distress syndrome (ARDS)?

Researchers explore the rates of readmission over the first year among children who survived acute respiratory distress syndrome.

12 Sep 2023

New ARDS definition could expand diagnosis and treatment options

In a new report posted online in the American Journal of Respiratory and Critical Care Medicine, a global consensus conference of 32 critical care experts with broad international representation and from diverse backgrounds has proposed a new definition of acute respiratory distress syndrome (ARDS).

5 Sep 2023

Mutational changes in Avian flu virus could increase risk of transmission to humans

A new study from researchers in China and Nottingham has discovered that a subtype of avian flu virus, endemic in poultry farms in China, is undergoing mutational changes, which could increase the risk of the disease being passed on to humans.

5 Sep 2023

Study investigates the pathophysiological mechanisms of PASC after COVID-19

Researchers investigated early pathophysiological mechanisms potentially underlying PASC post-SARS-CoV-2 infection.

4 Sep 2023

Obese adults with ARDS may benefit from ECMO

A National Institutes of Health-supported study suggests that adults with obesity may benefit from the use of extracorporeal membrane oxygenation (ECMO), an advanced form of breathing support, when in intensive care for respiratory failure.

28 Aug 2023

Differences in immune responses to IL-6 inhibition therapy between male and female COVID-19 patients

Researchers investigated whether anti‑interleukin 6 monoclonal antibodies were related to heterogenous treatment effects between male and female COVID-19 patients.

24 Aug 2023

Study reports the first protein-based diagnostic signature to discriminate MIS-C from Kawasaki Disease and other common infections

Researchers explore the distinguishing features of MIS-C as compared to other inflammatory-infectious syndromes in children.

4 Aug 2023

Revolutionizing COVID-19 ARDS prediction: a deep learning model for critically ill patients

Researchers developed and evaluated a deep learning model for predicting coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS).

31 Jul 2023

The impact of diabetes mellitus on morbidity and mortality in patients with COVID-19

Researchers examine the impact of DM on post-COVID-19 clinical outcomes.

31 Jul 2023

Study shows that COVID-19 patients presented different plasma trace elements levels depending on disease severity

Lower blood levels of certain trace elements are associated with critical COVID-19 outcomes.

31 Jul 2023

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes

A group of researchers compared the effects of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers.

27 Jul 2023

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

Researchers used a K18-hACE2 transgenic (ACE2.Tg) mouse model to demonstrate that interleukin-9 (IL-9).

13 Jul 2023

COVID-19 severity linked to autoantibodies against blood clotting protein

Study investigates the occurrence of ADAMTS13 antibodies in COVID-19 patients and their association with disease severity and lower ADAMTS13 activity. The findings suggest the need to include ADAMTS13 antibodies in diagnosing and managing SARS-CoV-2 infections.

2 Jul 2023

Investigating the relationship between red blood cells and the clinical course of COVID-19 in children

Study investigates the characteristics of RBCs after SARS-CoV-2.

20 Jun 2023

Therapeutic nanocarriers engineered from adult skin cells show promise for treating lung injury

Therapeutic nanocarriers engineered from adult skin cells can curb inflammation and tissue injury in damaged mouse lungs, new research shows, hinting at the promise of a treatment for lungs severely injured by infection or trauma.

6 Jun 2023

University of Louisville researchers receive $5.8 million to prevent immune system dysregulation

Researchers at the University of Louisville have received $5.8 million in two grants from the National Institutes of Health to expand their work to better understand and prevent immune system dysregulation responsible for acute respiratory distress, the condition responsible for serious illness and death in some COVID-19 patients.

2 Jun 2023

Risk of long COVID in the United Kingdom and Hong Kong cohorts

Study evaluates the risk of post-acute sequelae of COVID-19 in the United Kingdom (UK) and Hong Kong (HK).

30 May 2023

Acute Respiratory Distress Syndrome News and Research

Nanoparticle gene delivery system shows promise for treating ARDS

Cancer drug could play a role in limiting the damaging effects of lung disease in COVID-19 patients

SARS-CoV-2 infection can exacerbate production of auto-antibodies relating to auto-immune diseases

What factors are associated with readmission in pediatric survivors of acute respiratory distress syndrome (ARDS)?

New ARDS definition could expand diagnosis and treatment options

Mutational changes in Avian flu virus could increase risk of transmission to humans

Study investigates the pathophysiological mechanisms of PASC after COVID-19

Obese adults with ARDS may benefit from ECMO

Differences in immune responses to IL-6 inhibition therapy between male and female COVID-19 patients

Study reports the first protein-based diagnostic signature to discriminate MIS-C from Kawasaki Disease and other common infections

Revolutionizing COVID-19 ARDS prediction: a deep learning model for critically ill patients

The impact of diabetes mellitus on morbidity and mortality in patients with COVID-19

Study shows that COVID-19 patients presented different plasma trace elements levels depending on disease severity

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

COVID-19 severity linked to autoantibodies against blood clotting protein

Investigating the relationship between red blood cells and the clinical course of COVID-19 in children

Therapeutic nanocarriers engineered from adult skin cells show promise for treating lung injury

University of Louisville researchers receive $5.8 million to prevent immune system dysregulation

Risk of long COVID in the United Kingdom and Hong Kong cohorts

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News